Nuclear Medicine: Page 115

PET scans for lung and esophageal cancer may be overused

By Wayne Forrest

Multiple PET scans to evaluate post-treatment recurrence of lung and esophageal cancer do not improve two-year patient survival rates, which may mean the modality is overused, according to a study published online February 22 in the Journal of the National Cancer Institute.

February 25, 2016

Shine Medical moly plans move ahead

By AuntMinnie.com staff writers

The U.S. Nuclear Regulatory Commission has agreed to issue a construction permit to Shine Medical Technologies for a medical isotope manufacturing facility to be built in Janesville, WI.

February 24, 2016

Lantheus posts stable year-end revenue

By AuntMinnie.com staff writers

The parent company of Lantheus Medical Imaging, Lantheus Holdings, reported financial results for fiscal 2015 that were essentially stable after currency adjustments.

February 24, 2016

PET/MR enterography offers potential in Crohn's disease

By Wayne Forrest

The combination of FDG-PET and MR enterography can accurately differentiate fibrotic strictures and inflammation in patients with Crohn's disease, potentially helping patients avoid unnecessary surgery, according to a new study published in the March issue of Radiology.

February 18, 2016

Novel PET tracer could aid detection of tau deposits

By Wayne Forrest

Japanese researchers are reporting early success with a novel PET imaging tracer that enhances the detection of tau deposits in regions of the brain that are associated with the onset of cognitive impairment and Alzheimer's disease.

February 16, 2016

Senior Scientific teams with Weill Cornell

By AuntMinnie.com staff writers

Senior Scientific, a subsidiary of nanotechnology developer Manhattan Scientifics, has formed a research collaboration with Weill Cornell Medicine to explore the use of molecularly targeted nanoparticles for detecting and diagnosing prostate cancer.

February 15, 2016

Navidea launches Lymphoseek cervical cancer study

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has enrolled the first patient in a clinical study that will evaluate the use of its Lymphoseek radiopharmaceutical in women with known cervical cancer.

February 10, 2016

IsoRay posts mixed Q2 results

By AuntMinnie.com staff writers

Medical isotope developer IsoRay Medical added to both its revenue and net loss in the company's second quarter of fiscal 2016.

February 9, 2016

Is visual or automated analysis best to assess Alzheimer's?

By Wayne Forrest

Should visual or automated analysis be used with PET imaging to predict a person's progression from mild cognitive impairment to dementia due to Alzheimer's, based on a two-year follow-up evaluation? It could depend on the radiotracer involved.

February 9, 2016

PET, MRI find link between TBI and Alzheimer's

By AuntMinnie.com staff writers

A combination of PET and MRI scans suggests that people with traumatic brain injury (TBI) may have buildup of the plaques related to Alzheimer's disease in their brains, according to a new study published online February 3 in Neurology.

February 2, 2016

Mallinckrodt nuclear imaging sales edge higher in Q1

By AuntMinnie.com staff writers

In a quarter that saw Mallinckrodt sell off its Contrast Media and Delivery Systems business to French contrast developer Guerbet, the company posted a modest increase in revenues for its remaining nuclear imaging business.

February 1, 2016

New PET tracer aids in metastatic prostate cancer

By AuntMinnie.com staff writers

PET/CT scans with a radiotracer that targets prostate-specific membrane antigen are significantly more effective than other detection methods currently in use.

January 27, 2016

Previous Page

Page 115 of 438

Next Page